The exon junction complex (EJC) is an essential constituent and regulator of spliced messenger 33 ribonucleoprotein particles (mRNPs) in metazoans. As a core component of the EJC, CASC3 was 34 described to be pivotal for EJC-dependent nuclear and cytoplasmic processes. However, recent 35 evidence suggests that CASC3 functions differently from other EJC core proteins. Here, we have 36 established human CASC3 knockout cell lines to elucidate the cellular role of CASC3. In the knockout 37 cells, overall EJC composition and EJC-dependent splicing are unchanged. A transcriptome-wide 38 analysis reveals that hundreds of mRNA isoforms targeted by nonsense-mediated decay (NMD) are 39 upregulated. Mechanistically, recruiting CASC3 to reporter mRNAs by direct tethering or via binding to 40 the EJC stimulates mRNA decay and endonucleolytic cleavage at the termination codon. Building on 41 existing EJC-NMD models, we propose that CASC3 equips the EJC with the ability to communicate with 42 the NMD machinery in the cytoplasm. Collectively, our results characterize CASC3 as a peripheral EJC 43 protein that tailors the transcriptome by promoting the degradation of EJC-dependent NMD 44 substrates. 45 46 Messenger RNA-binding proteins (mRBPs) determine the stability, location, efficiency of 48 translation and fate of bound mRNAs and are therefore important regulators of post-transcriptional 49 gene expression (1). A central component of spliced mRNPs in metazoans is the exon-junction-complex 50 (EJC), which is deposited during splicing upstream of exon-exon boundaries (2-4). The 51 heterotetrameric core of the EJC is composed of the proteins EIF4A3, MAGOH, RBM8A (Y14) and CASC3 52 (BTZ, MLN51) (5,6). Generally, EJCs serve on spliced mRNAs as a mark that act as a binding platform 53 for peripheral EJC-interacting factors (7). The core and peripheral EJC components contribute to 54 different steps of post-transcriptional gene expression including splicing regulation, mRNA localization, 55 translation and nonsense-mediated mRNA decay (NMD) (2,4). 56
Introduction 47 in 10 cm dishes using 10 µl Lipofectamine RNAiMAX and 300 pmol siRNA. siRNAs were targeted against 114
Luciferase (5′-CGTACGCGGAATACTTCGA-3′), EIF4A3 (5′-AGACATGACTAAAGTGGAA-3′), RBM8A (5′-115 TTCGCAGAATATGGGGAAA-3′), CASC3 (5′-CTGATGACATCAAACCTCGAAGAAT-3′, 5′-116 CGTCATGAACTTTGGTAATCCCAGT-3′), UPF1 (5′-GATGCAGTTCCGCTCCATT-3′), XRN1 (5′-117 AGATGAACTTACCGTAGAA-3′), SMG6 (5′-GGGTCACAGTGCTGAAGTA-3′) or SMG7 (5′-118 CGATTTGGAATACGCTTTA-3′). 119
Generation of knockout cells using CRISPR-Cas9 120
The knockouts were performed using the Alt-R CRISPR-Cas9 system (IDT) and reverse transfection 121 of a Cas9:guideRNA ribonucleoprotein complex using Lipofactamine RNAiMAX (Thermo Fisher 122 Scientific) according to the manufacturer's protocol. The crRNA sequences to target CASC3 were 123 /AlTR1/rGrCrGrCrGrCrUrUrCrGrCrArArGrArCrArCrCrGrGrUrUrUrUrArGrArGrCrUrArUrGrCrU/AlTR2/ 124 (clone H) and 125 /AlTR1/rGrUrUrCrGrGrCrCrUrCrCrGrCrGrCrUrGrUrGrArGrUrUrUrUrArGrArGrCrUrArUrGrCrU/AlTR2/ 126 (clones F and T). Reverse transfection was performed on 1.5x10 5 cells per crRNA in 12-well dishes. 127 48 hours after transfection the cells were trypsinized, counted and seeded at a density of a single cell 128 per well in 96-well plates. Cell colonies originating from a single clone were then validated by Sanger 129 sequencing of the targeted genomic DNA locus and western blotting. 130 Plasmid transfection 131 All used plasmids are listed in Supplementary Table S1 . To express FLAG-tagged protein constructs 132 and the reporter mRNAs detected by northern blotting, the cells were stably transfected using the In T-REx system and the tetracycline inducible pcDNA5/FRT/TO vector (Thermo Fisher Scientific). The 134 constructs TPI-WT, TPI-PTC, β-globin WT and β-globin PTC are available on Addgene (IDs 108375-135 108378). 2.5x10 5 cells were seeded 24 h before transfection in 6-wells. Per well, 1 µg of reporter 136 construct was transfected together with 1 µg of the Flp recombinase expressing plasmid pOG44 using 137 the calcium phosphate method. 48 h after transfection, the cells were transferred into 10 cm dishes 138 and selected with 100 µg/ml hygromycin. After 10 days, the colonies were pooled. Expression of the 139 reporter mRNA was induced with 1 µg/ml doxycycline for 24 h. 140
Constructs that express V5-tagged and MS2V5-tagged proteins were stably integrated into the 141 cells using the PiggyBac (PB) Transposon system and the cumate-inducible PB-CuO-MCS-IRES-GFP-EF1-142
CymR-Puro vector (System Biosciences). 2.5x10 5 cells were seeded 24 h before transfection in 6-wells. 143 2.5 µg of the PB Transposon vector and 0.8 µg of PB Transposase were transfected per well using the 144 calcium phosphate method. After 48 h, the cells were pooled in 10 cm dishes and positive clones 145 selected with 2 µg/ml puromycin for a week. Expression of proteins was induced using 30 µg/ml 146 cumate for 72 h. 147
The tethering construct pSBtet-Hyg-TPI-4MS2-SMG5-4H was stably integrated into HeLa Tet-Off 148 cells using the Sleeping Beauty (SB) transposon system (35, 36) . pSBtet-Hyg was a gift from Eric Kowarz 149 (Addgene plasmid #60508; http://n2t.net/addgene:60508; RRID:Addgene_60508). pCMV(CAT)T7-150 SB100 was a gift from Zsuzsanna Izsvak (Addgene plasmid #34879; http://n2t.net/addgene:34879; 151 RRID:Addgene_34879). 2.5x10 5 cells were seeded 24 h before transfection in 6-wells. Per well, 1 µg of 152 the reporter construct was transfected together with 1.5 µg of the SB Transposase using the calcium 153 phosphate method. 48 h after transfection, the cells were transferred into 10 cm dishes and selected 154 with 100 µg/ml hygromycin. After 10 days, the colonies were pooled. In absence of tetracycline the 155 reporter was constitutively expressed. 156
RNA-Sequencing and computational analyses
157 RNA-Seq analysis was carried out with 293 wild type (WT) cells transfected with Luciferase siRNA 158 and the CASC3 KO clones H and T transfected with either Luciferase or CASC3 siRNAs. Three biological 159
replicates were analyzed for each sample. RNA was isolated with the kit NucleoSpin RNA Plus 160 (Macherey-Nagel). The Lexogen SIRV Set1 Spike-In Control Mix (SKU: 025.03) that provides a set of 161 external RNA controls was added to the total RNA to enable performance assessment. Mix E0 was 162 added to replicate 1, mix E1 was added to replicate 2 and mix E2 to replicate 3. The Spike-Ins were not 163 used for analysis. The library preparation was performed with the TrueSeq Stranded Total RNA kit 164 (Illumina) . First steps of the library preparation involve the removal of ribosomal RNA using 165 biotinylated target-specific oligos combined with Ribo-Zero Gold rRNA removal beads from 1 µg total 166 RNA input. The Ribo-Zero Gold Human/Mouse/Rat kit depletes samples of cytoplasmic and 167 mitochondrial rRNA. Following purification, the RNA is fragmented and cleaved. RNA fragments are 168 copied into first strand cDNA using reverse transcriptase and random primers, followed by second 169 strand cDNA synthesis using DNA Polymerase I and RNase H. These cDNA fragments then have the 170 addition of a single'A' base and subsequent ligation of the adapter. The products are purified and 171 enriched with PCR to create the final cDNA library. After library validation and quantification (Agilent 172 tape station), equimolar amounts of library were pooled. The pool was quantified by using the Peqlab 173 KAPA Library Quantification Kit and the Applied Biosystems 7900HT Sequence Detection System and 174 sequenced on an Illumina NovaSeq6000 sequencing instrument and a PE100 protocol. 175 Read processing and alignment was performed as described previously (37). In short, adaptor 176 sequences and low quality bases were removed with Flexbar 3.0 (38). Short reads from the rRNA locus 177 were subtracted by mapping against the 45S precursor (Homo sapiens, NR_046235.1) using Bowtie2 178 (39) . The remaining reads were aligned against the human genome (version 38, EnsEMBL 90 transcript 179 annotations) using the STAR read aligner (version 2.5.3a) (40). 180
To compute gene differential expression analysis, reads covering exons were counted with 181 FeatureCounts (version 1.5.1) (41) using the '-primary' and '-ignoreDup' parameters. Differential 182 gene expression analysis was performed with DESeq2 (42,43) and IWH R packages. Significance 183 thresholds were |log2FoldChange|> 1 and adjusted p-value (padj) < 0.05. Genes were designated as 184 small RNA (sRNA) host gene, if they contained other Ensembl-annotated genes of biotypes snoRNA or 185 miRNA within their genomic coordinates (44). 186
Differential splicing was detected with LeafCutter (version 0.2.7) (45) with the parameters 187 min_samples_per_intron = 2 and min_samples_per_group = 2. Significance thresholds were |deltapsi| 188 > 0.1 and adjusted p-value (p.adjust) < 0.05. 189
Transcript abundance estimates were computed with Salmon (version 0.13.1) (46) using the the -190 validateMappings --gcBias parameters. Differential transcript usage was computed with 191 IsoformSwitchAnalyzeR (version 1.7.1) and the DEXSeq method (47-52). Significance thresholds were 192 |dIF| > 0.1 and adjusted p-value (isoform_switch_q_value) < 0.05. For the Smirnoff test, the data were filtered only for the adjusted p-value. PTC status of transcript isoforms 194 with annotated open reading frame was determined by IsoformSwitchAnalyzeR using the 50 nt rule of 195 NMD (49, [53] [54] [55] . Isoforms with no annotated open reading frame in Ensembl were designated " NA" in 196 the PTC analysis. 197 The UPF1 and SMG6/7 (56) and RNPS1 (57) knockdown datasets were processed and analyzed 198 with the same programs, program versions, and scripts as the CASC3 dataset. All packages used are 199 listed in the respective analysis table (Supplementary Tables S4-6 ). Overlaps of data sets were 200 represented via nVenn (58), eulerr (59) and Upset plots (60). Heatmaps were generated using 201 ComplexHeatmap (61). Barcode plots were produced with barcodeplot function from the limma 202 package version 3.38.3 (50) using transcript isoform dIF as ranking statistic. To test the significance of 203 this enrichment, we used the function cameraPR, from the same package, with the use.rank parameter 204 set to TRUE (62). 205 SILAC, co-immunoprecipitation and mass spectrometry 206 293 WT and 293 CASC3 KO clone H cells expressing either FLAG or FLAG-EIF4A3 were labeled by 207 maintaining them for 5 passages in DMEM for SILAC medium (Thermo Fisher Scientific) supplemented 208 with FBS (Silantes), Penicillin-Streptomycin (Thermo Fisher Scientific) and the respective amino acids 209 at a final concentration of 0.798 mmol/L (Lysine) and 0.398 (Arginine). Unlabeled proline was added 210 to prevent enzymatic Arginine-to-Proline conversion. The conditions were "light" (unlabeled 211 Lysine/Arginine), "medium" (Lysine 4/Arginine 6) and "heavy" (Lysine 8/Arginine 10). A label switch 212 was performed between the three replicates according to the experimental setup listed in 213 Supplementary Table S2 . 24 h before expression of the FLAG-tagged construct, the CASC3 KO clone H 214 cells were treated with siRNA against CASC3. The expression of FLAG or FLAG-EIF4A3 was induced for 215 72 h with 1 µg/ml doxycycline. The cells were lysed in buffer E with RNAse (20 mM HEPES-KOH (pH 216 7.9), 100 mM KCl, 10% glycerol, 1 mM DTT, Protease Inhibitor, 1 µg/ml RNAse A) and sonicated using 217 the Bandelin Sonopuls mini20 with 15 pulses (2.5 mm tip in 600 µl volume, 1s, 50% amplitude). 600 µl 218 of a 1.6 mg/ml total protein lysate were incubated with 30 µl Anti-FLAG M2 magnetic beads (Sigma) at 219 4°C while rotating for 2 h. The beads were washed three times for 5 min with EJC-buffer (20 mM HEPES-220 KOH (pH 7.9), 137 mM NaCl, 2 mM MgCl2, 0.2% Triton X-100, 0.1% NP-40) and eluted in 43 µl of a 200 221 mg/ml dilution of FLAG peptides (Sigma) in 1x TBS. The samples were merged according to 222 Supplementary Table S2 . 1 volume of 10% SDS was added and the samples were reduced with DTT and 223 alkylated with CAA (final concentrations 5 mM and 40 mM, respectively). Tryptic protein digestion was 224 performed using a modified version of the single pot solid phase-enhanced sample preparation (SP3) 225 (63). In brief, reduced and alkylated proteins were supplemented with paramagnetic Sera-Mag speed 226 beads (Thermo Fisher Scientific) and mixed in a 1:1-ratio with 100% acetonitrile (ACN). After 8 min 227 incubation protein-beads-complexes were captured using an in-house build magnetic rack and two 228 times washed with 70% EtOH. Afterwards, samples were washed once with 100% ACN, air-dried and 229 reconstituted in 5 µl 50 mM Triethylamonium bicarbonate supplemented with 0.5 µg trypsin and 0.5 230 µg LysC and incubated overnight at 37°C. On the next day, the beads were resuspended and mixed 231 with 200 µl ACN, incubated for 8 min and again placed on the magnetic rack. Tryptic peptides were 232 washed once with 100% ACN, airdried, dissolved in 4% DMSO and transferred into 96-well PCR tubes. 233
After acidification with 1 µl of 10% formic acid, the samples were ready for LC-MS/MS analysis. 234 Proteomics analysis was performed by data-dependent acquisition using an Easy nLC1200 ultra 235 high-performance liquid chromatography (UHPLC) system coupled via nanoelectrospray ionization to 236 a Q Exactive Plus instrument (all Thermo Scientific). Tryptic peptides were separated based on their 237 hydrophobicity using a chromatographic gradient of 60 min with a binary system of buffer A (0.1% 238 formic acid) and buffer B (80% ACN, 0.1% formic acid). In-house made analytical columns (length: 50 239 cm, inner diameter: 75 µm) filled with 1.9 µm C18-AQ Reprosil Pur beads (Dr. Maisch) were used for 240 separation. Buffer B was linearly increased from 3% to 27% over 41 min followed by a steeper increase 241 to 50% within 8 min. Finally, buffer B was increased to 95% within 1 min and stayed at 95% for 10 min 242 in order to wash the analytical column. Full MS spectra (300 -1,750 m/z) were acquired with a 243 resolution of 70,000, a maximum injection time of 20 ms, and an AGC target of 3e6. The top 10 most 244 abundant peptide ions of each full MS spectrum were selected for HCD fragmentation (NCE: 27) with 245 an isolation width of 1.8 m/z and a dynamic exclusion of 10 seconds. MS/MS spectra were measured 246 with a resolution of 35,000, a maximum injection time of 110 ms and an AGC target of 5e5. 247 MS RAW files were analysed using the standard settings of the MaxQuant suite (version 1.5.3.8) 248
with the before mentioned SILAC labels (64). Peptides were identified by matching against the human 249
UniProt database using the Andromeda scoring algorithm (65). Carbamidomethylation of cysteine was 250 set as a fixed modification, methionine oxidation and N-terminal acetylation as variable modification. 251 Trypsin/P was selected as the digestion protein. A false discovery Rate (FDR) < 0.01 was used for 252 identification of peptide-spectrum matches and protein quantification. Data processing and statistical 253 analysis was done in the Perseus software (version 1.5.5.3) (66). Significantly changed proteins were 254 identified by One-sample t-testing (H0 = 0, fudge factor S0 = 0.1). The results are listed in 255 Supplementary Table S2 . Visualization was performed with the Instant Clue software (version 0.5.3) 256 and the R package ggplot2 (version 3.1.0) (67,68). 257
Co-immunoprecipitation experiments followed by western blotting were performed as described 258 above except that a 15 min incubation step in SDS buffer (600 mM Tris pH 6.8, 100 mM DTT, 10% 259 Glycerol, 2% SDS, 0.002% Bromophenolblue) was used for elution from the beads. replicates were calculated according to the ΔΔCt method (69). When measuring isoform switches, the 268 fold change of the PTC-containing transcript was normalized to the canonical transcript. When 269 measuring differential expression, the fold change was normalized to GAPDH. For each primer pair 270 amplification efficiencies were measured by a 2-fold dilution curve and ranged between 87 and 271 100.1%. The primer sequences are listed in Supplementary Table S3 . 272
Western blotting 273
Protein extraction was performed with peqGOLD TriFast reagent (VWR), and proteins were 274 separated by SDS-PAGE gel electrophoresis and transferred to a PVDF membrane (GE Healthcare Life 275 Sciences). The following antibodies were used: anti-CASC3 amino acid residues Laboratories, #A302-472A-M), anti-CASC3 amino acid residues 367-470 (Atlas Antibodies, 277 #HPA024592), anti-EIF4A3 (Genscript), anti-FLAG (Cell Signaling Technology, #14793), anti-RBM8A 278 (Atlas Antibodies, #HPA018403), anti-SMG6 (Abcam, #ab87539), anti-SMG7 (Elabscience, #E-AB-279 32926), anti-Tubulin (Sigma-Aldrich, #T6074), anti-V5 (QED Bioscience, #18870), anti-XRN1 (Bethyl 280
Laboratories, #A300-443A), anti-rabbit-HRP (Jackson ImmunoResearch, #111-035-006), anti-mouse-281 HRP (Jackson ImmunoResearch, #115-035-003). Detection was performed with Western Lightning 282
Plus-ECL (PerkinElmer) or Amersham ECL prime (Ge Healthcare Life Sciences) and the 283 chemiluminescence imager Fusion FX6 EDGE (Vilber-Lourmat). 284
Northern blotting 285
The cells were harvested in peqGOLD TriFast reagent (VWR) and total RNA extraction was 286 performed as recommended by the manufacturer's protocol. 2.5 μg of total RNA were resolved on a 287 1% agarose/0.4 M formaldehyde gel using the tricine/triethanolamine buffer system (70) followed by 288 a transfer on a nylon membrane (Roth) in 10x SSC. The blots were incubated overnight at 65°C in 289
Church buffer containing [α-32P]-GTP body-labeled RNA probes for detection of the reporter mRNA. 290
Endogenous 7SL RNA was detected by a 5′-32P-labeled oligonucleotide (5′-291 TGCTCCGTTTCCGACCTGGGCCGGTTCACCCCTCCTT-3′). The blots were visualized and quantified using a 292 Typhoon FLA 7000 (GE Healthcare) and ImageQuant TL 1D software. 293
Results

294
CASC3 is dispensable for the correct splicing of many EJC-dependent transcripts 295 Previously, we and others have shown that the depletion of EJC core components in human 296 cells leads to pervasive re-splicing of cryptic splice sites, resulting in aberrant splice variants lacking 297 exonic sequences (37,71). Mechanistically, the EJC prevents the use of cryptic splice sites either by 298 interaction with the ASAP/PSAP component RNPS1 or by sterically masking splice sites 299 (schematically depicted in Supplementary Figure S1A) (37). In keeping with previous observations 300 from HeLa cells, the knockdowns of the EJC core components EIF4A3 or RBM8A in HEK293 cells 301 resulted in exon-skipping of the mRNAs for RER1, OCIAD1 and MRPL3 ( Figure 1A-C) . Surprisingly, 302 when we performed a knockdown of the EJC core factor CASC3 this did not result in mis-splicing 303 of these three selected transcripts ( Figure 1A -C). This observation stands in contrast to a previous 304 study that has reported transcriptome-wide alternative splicing upon CASC3 depletion, including 305 MRPL3 (71,72). Interestingly, the knockdown of CASC3 increased the abundance of an alternative 306 transcript isoform of the SR protein SRSF2 ( Figure 1D ), which was previously shown to be regulated 307 by NMD. Although this altered abundance of the NMD-targeted SRSF2 transcript isoform could be 308 due to alternative splicing, we consider it very likely that reduced NMD is responsible for this 309 effect. 310
Although the knockdown efficiency of CASC3 was substantial (Supplementary Figure S1B) , 311
we wished to exclude that residual amounts of CASC3 prevented a reliable assessment of the 312 protein's function. Since CASC3 was found to be non-essential in multiple genome-wide screens of 313 human immortalized cell lines, we reasoned that knockout (KO) of CASC3 should be feasible 314 (73, 74) . Accordingly, we obtained three cell lines by CRISPR-Cas9-mediated gene editing, 315 designated H, F, and T lacking the CASC3-specific 130 kDa band on a western blot ( Figure 1E ). In all 316 cell lines we detected genomic insertions of different length and sequence at the beginning of the 317 coding region of CASC3, which resulted in frame shifts of the downstream coding region or, in the 318 case of cell line T, contained in-frame termination codons ( Figure 1F , Supplementary Figure S1C 319 and D). For the cell lines H and F, we observed an additional band of 100 kDa on western blots with 320 antibodies recognizing the C-terminal or central region of CASC3 ( Figure 1E , red arrow, 321
Supplementary Figure S1C and E). This cross-reactive protein interacted with FLAG-tagged EIF4A3 322 and disappeared upon treatment with siRNAs against CASC3 ( Figure 1G , Supplementary Figure S1E  323 and F). This suggests that the cell lines H and F produce an N-terminally truncated form of CASC3, 324 presumably by initiating protein translation at a non-canonical initiation codon. The production of 325 aberrant protein forms by alternative translation initiation has been recently described in a 326 systematic analysis to commonly occur in KO cell generated by CRISPR-Cas9 genome editing 327 (75, 76) . The cell line T (without further treatment) and cell line H in combination with CASC3 siRNA 328 treatment completely lack detectable CASC3 protein. This set of cell lines therefore enables a 329 hitherto unfeasible analysis of CASC3's cellular function. 330
In agreement with the data obtained from the knockdown of CASC3, transcripts containing 331 EJC-dependent splice sites were correctly spliced in CASC3 KO cells ( Figure 1H and I, Supplementary 332 Figure S1G and H). Remarkably, the increased abundance of the NMD-regulated SRSF2 transcript 333 isoform was much more prominent in the CASC3 KO than in the CASC3 knockdown ( Figure 1J ). 334 CASC3 regulates NMD-sensitive isoforms 335 So far, our results have indicated that CASC3 shapes the transcriptome differently 336 compared to EIF4A3, MAGOH and RBM8A. To investigate the global effects of CASC3 depletion on 337 the transcriptome, we performed RNA-sequencing (RNA-seq) of the cell lines H and T either 338 treated with CASC3 or control siRNAs ( Figure 2A ) and identified differentially expressed genes 339 (Supplementary Figure S2A and B, Supplementary Table S4 ). To exclude clone-specific and siRNA 340 treatment-related effects, we compared the identified targets between the four conditions. 341
Overall, the high number and the substantial overlap of upregulated genes suggests that CASC3 342 KO mainly results in the accumulation of certain transcripts ( Figure 2B and C, Supplementary Figure  343 S2C). Interestingly, several upregulated genes belong to the class of small RNA (e.g. snoRNA) host 344 genes, which are frequently NMD targets ( Figure 2C and D) (31, 33) . We validated the upregulation 345 of the snoRNA host gene ZFAS1 by qPCR, which was even more pronounced in CASC3 KO than 346 UPF1 knockdown cells (Supplementary Figure S2D and E). Across the top 100 significantly 347 upregulated genes in CASC3 KO, 15 small RNA host genes were identified ( Figure 2D ). Comparing 348 the differentially expressed genes to recent transcriptome-wide NMD screens, many of the top 349 100 significantly upregulated genes were also differentially expressed in UPF1 and SMG6/7 KD 350 ( Figure 2D , 23% and 59%, respectively) (31,56). However, none of the identified targets were 351 present in an RNPS1 knockdown ( Figure 2D ) (37,57). Collectively, our differential gene expression 352 analysis strengthens the proposed link between CASC3 and the NMD-machinery. 353
Next, we analyzed alternative splicing changes in CASC3 KO cells ( Figure 2E ). Since our earlier 354 assays showed that CASC3 was not involved in the EJC-regulated splicing of many targets ( Figure  355 1), we were surprised to detect many altered splicing events in CASC3 depleted cells 356 (Supplementary Figure S2F , Supplementary Table S5 ). It is remarkable that hardly any alternative 357 splicing events were shared between RNPS1 knockdown and CASC3 KO cells ( Figure 2E , 358 Supplementary Figure S2F ). Either CASC3 regulates an RNPS1-independent set of alternative splice 359 sites or the splicing changes are due to impaired NMD, which fails to remove NMD-sensitive 360 isoforms. To test these possibilities, we investigated the functional consequence of CASC3-361 dependent alternative splicing on the transcript isoform level ( Figure 3A , Supplementary Figure  362 S3A and B, and Supplementary Table S6 ). Strikingly, in all CASC3 KO conditions many upregulated 363 mRNA isoforms contained a premature termination codon (PTC), rendering the transcripts 364 susceptible to NMD ( Figure 3A ). On the other hand, downregulated isoforms rarely contained a 365 PTC. Among the identified isoform switches was the target SRSF2, which we confirmed earlier to 366 be CASC3-dependent ( Figure 1D and J). While overall SRSF2 gene expression varied only slightly 367 between wild-type and CASC3 KO cells, the isoform usage changed dramatically towards the 368 accumulation of NMD-sensitive transcripts in the CASC3 KO conditions ( Figure 3B ). A similar 369 accumulation of NMD-sensitive transcripts was also observed for other transcripts (Supplementary 370 Figure S3C -E). 371
We next validated a set of transcript isoform switches by qPCR ( Figure 3C -E, Supplementary Figure  372 S3F and G). In the transcript isoforms stabilized by the CASC3 KO and by a UPF1 KD, the inclusion 373 of intronic regions resulted in the inclusion of PTCs. The shift of isoform usage from NMD-374 insensitive to PTC-containing transcripts was also observed transcriptome-wide in CASC3 KO cells 375
and was comparable to NMD-compromised SMG6/7 or UPF1 depleted cells ( Figure 3F ). When 376 compared to transcript isoform changes in a SMG6/7 knockdown, the events in the CASC3 KO are 377 enriched in a similar fashion ( Figure 3G ). While the enrichment is stronger in a comparison of UPF1 378 and SMG6/7, the isoform changes occurring in the RNPS1 KD do not correlate with the ranked 379 SMG6/7 events ( Figure 3G, Supplementary Figure S3H ). These findings indicate that many 380 transcript isoforms upregulated upon depletion of CASC3 represent genuine endogenous NMD 381
targets. 382
The EJC core is undisturbed if CASC3 is not present 383 The CASC3 KO could potentially influence the composition of exon junction complexes and 384 their peripheral interacting proteins, which could underlie the observed effects on the 385 transcriptome. Therefore, we analyzed the FLAG-tagged EIF4A3 interactome in the cell line H 386 treated with CASC3 siRNAs and wild type cells using mass spectrometry. EIF4A3 was successfully 387 enriched, together with other known EJC complex members ( Figure 4A and B, Supplementary 388 Figure S4 ). Co-precipitated CASC3 was reduced to background levels in the knockout condition, 389 further validating the absence of CASC3 in the EJC ( Figure 4B and C, log2 fold change = -4.34). We 390 were interested to identify factors that significantly changed between the KO and WT condition. 391
These belong to three distinct groups: significant in both WT/CTL and KO/CTL conditions (blue 392 dots), significant in KO/CTL (orange dots), and significant in WT/CTL (magenta dots). In the first 393 group, no factor was changed between the WT and KO condition more than 1.6 fold 394 (Supplementary Figure S4 ). In the second group three factors were negatively enriched in the 395 KO/CTL condition or marginally altered between KO and WT conditions ( Figure 4B and C, WARS, 396 CMBL and USP15). 397
The only other protein besides CASC3 that was significantly changed between KO/WT and only 398 enriched in the WT/CTL condition was the NMD factor UPF3B ( Figure 4C , log2 fold change = -1.52). 399 UPF3B links the EJC to the NMD machinery via direct interactions (77) and was recently found to 400 be enriched in cytoplasmic CASC3-loaded EJCs (22). The reduction of NMD-competent EJCs could 401 contribute to the NMD impairment that we observed upon loss of CASC3. Strikingly, no other EJC 402 core factor or splicing regulatory EJC component (e.g. ASAP/PSAP) was considerably altered in the 403 CASC3-depleted condition ( Figure 4D ). 404
CASC3 stimulates SMG6-dependent endonucleolytic cleavage 405
To deepen the understanding of how a lack of CASC3 results in reduced NMD efficiency, we 406 stably integrated the well-established globin NMD reporter PTC39 in WT and CASC3 KO cell lines 407 ( Figure 5A and B, Supplementary Figure S5A ) (78). The analysis of a reporter mRNA enables a read-408 out of multiple aspects of mRNA degradation: firstly, the total levels of the full-length reporter, 409 secondly the contribution of 5′->3′ exonucleolytic decay by XRN1 (detection of xrFrag due to an 410 XRN1-resistant element) (79,80); and thirdly the amount of endonucleolytic cleavage by SMG6 411 (detection of 3′ fragment stabilized by XRN1 knockdown). In both WT and CASC3 KO cell lines the 412 reporter was efficiently degraded, showing that the NMD pathway is still functional in CASC3 413 depleted cells. However, full-length reporter levels in CASC3 KO were slightly higher when 414 compared to wild-type cells (lane 2 vs. lane 5). Notably, the accumulation of 3′ fragments following 415 XRN1 knockdown was clearly reduced in the CASC3 KO condition (lane 3 vs. lane 6). This difference 416 in endonucleolytic cleavage efficiency was also observed when expressing a minigene reporter of 417 the endogenous CASC3 target TOE1. While there was a substantial upregulation of full-length 418 reporter mRNA in CASC3 KO cells, the amount of the 3′ fragment was strongly reduced, suggesting 419 that SMG6-dependent endonucleolytic cleavage is inefficient in CASC3 KO cells ( Figure 5C -E, 420
Supplementary Figure S5B and C). To further address this, a TPI reporter was expressed in 421 combination with knockdowns of XRN1, SMG6 and/or SMG7 ( Figure 5F and G, Supplementary 422 Figure S5D ). The degree of reporter and 3′ fragment stabilization of the TPI reporter following XRN1 423 knockdown was comparable to the observations made for the globin and TOE1 reporters (lanes 1-424 3 vs. lanes 6-8). In both WT and CASC3 KO cells, the SMG6 knockdown resulted in a drastic 425 reduction of 3′ fragments, as expected (lanes 4 and 9) . Notably, a knockdown of SMG7 together 426 with XRN1 revealed a major difference between the cell lines. In WT cells the PTC-containing 427 reporter was only minimally stabilized by the SMG7/XRN1 knockdown and 3′ fragments were 428 unaffected. Performing a SMG7/XRN1 knockdown in CASC3 KO cells lead to a more dramatic 429 stabilization of the full-length reporter and a decrease of 3′ fragments compared to the XRN1 430 knockdown condition (lanes 3 and 5 vs. lanes 8 and 10). Collectively, our results indicate that in 431 CASC3 KO cells SMG6-mediated endonucleolytic cleavage is impaired. This could explain why the 432 CASC3 KO cells are more sensitive to a knockdown of SMG7 when compared to wild type cells. 433
To identify, which part of CASC3 promotes NMD, we employed a tethering reporter that was 434 designed to monitor mRNA turnover as well as endonucleolytic cleavage at the termination codon 435 ( Figure 6A ). Tethering the full-length CASC3 protein to the MS2 stem loops downstream of the stop 436 codon resulted in degradation of the reporter compared to tethering of the negative control GST, 437 as was previously reported for similar tethering reporters ( Figure 6B and C, Supplementary Figure  438 S6) (12,32). This degradation was accompanied by the production of 3′ fragments in XRN1 439 knockdown conditions, indicating that the mechanism of decay is comparable to the PTC-440 containing reporter mRNAs ( Figure 6B, lane 6) . Surprisingly, C-terminally truncated deletion 441 mutants of CASC3 that contain the first 480 or even 137 amino acid residues were able to induce 442 degradation of the tethering reporter to a comparable extent as full-length CASC3 ( Figure 6B, lanes  443   3 and 4, 7 and 8) . 444
Finally, CASC3 deletion mutants were expressed in the CASC3 KO cells to identify the minimal 445 part necessary to rescue the effects on endogenous NMD targets ( Figure 6D-F) . As in the tethering 446 experiment, the expression of full-length CASC3 and the C-terminal truncated variant 1-480 447 resulted in transcript isoform levels comparable to wild-type cells for the targets CLN6 and TOE1 448 ( Figure 6D lanes 1-4) . An EJC binding-deficient mutant of CASC3 (188/218 double point mutation) 449 was unable to rescue, supporting the notion that CASC3 is recruited to the mRNA by binding to the 450 EJC ( Figure 6D, lane 5) . Deleting the N-terminal 109 amino acids of CASC3 (110-480) did not alter 451 the rescue ability ( Figure 6D, lane 6) . While in the tethering assay it was sufficient to place the N-452 terminus downstream of a termination codon, this part of CASC3 was not necessary to rescue NMD 453 activity in the KO cells. This suggests that different domains of CASC3 act in a redundant manner 454 during the activation of NMD by the EJC. 455
Discussion
456
The role of CASC3 within the EJC has been the subject of scientific controversy for many years. 457 CASC3 has been initially described as an EJC core protein, because it was required for the assembly of 458 the EJC from recombinant protein components in vitro (21). However, it has been demonstrated that 459 the mechanism of EJC assembly using recombinant proteins is mechanistically different from EJC 460 assembly in splicing extracts or in living cell (11). Furthermore, several recent publications challenged 461 the view of CASC3 being an EJC core component. For instance, CASC3 was reported to be present in 462 substoichiometric amounts compared to the other three EJC core proteins EIF4A3, RBM8A, and 463 MAGOH in HEK293 (7) and U2OS cells (81). Also, during mouse embryonic brain development CASC3 464 deficiency results in a different phenotype than the other EJC core components (82). By using CASC3 465 CRISPR-Cas9 knockout cells, we unambiguously establish that CASC3 is not required for EJC assembly 466 or EJC-regulated splicing in the nucleus (Figure 7) . Even previously reported CASC3-dependent 467 alternative splice events (71) were not detectable in any of our KO or KD conditions. Therefore, our 468 molecular analyses fully support the recently emerging view of defining CASC3 as a peripheral EJC 469 component. As a mainly cytoplasmic component of the EJC we propose that the principal role of CASC3 470 is to alter the efficiency by which NMD-sensitive transcript isoforms are degraded. 471
Although NMD has been extensively studied in the past decades and many NMD factors have been 472 identified and characterized, no universal model exists that describes how they work together to elicit 473 NMD. While a function of CASC3 in NMD has been reported before, previous analyses did not show 474 consistent results, ranging from a substantial contribution of CASC3 to only a minor role in NMD 475 (12, 17, 22, 34) . In addition, none of the previous publications performed transcriptome-wide analyses 476 but concentrated on reporter mRNAs of only a few selected endogenous NMD targets. We reasoned 477 that the inconsistent results in the literature may be influenced by variable CASC3 knockdown 478 efficiency. By generating CASC3 knockout cell lines, we can for the first time analyze the global effects 479 of a complete depletion of CASC3 on the transcriptome and can exclude that residual CASC3 protein 480 masks these effects. Interestingly, the CASC3 knockout cells appear phenotypically normal, unlike 481 when the EJC components EIF4A3, RBM8A, or MAGOH are depleted. Nonetheless, since CASC3 is 482 required for mouse embryogenesis and involved in the transport of mRNAs in D. melanogaster, it is 483 likely that CASC3 downregulation in highly specialized cell types such as neurons or in developing 484 tissues would result in a more severe phenotype compared to HEK293 cells. 485
In recent years, high-throughput RNA-sequencing became an increasingly important method for 486 the analysis of NMD. Several RNA-Seq datasets of cells with NMD-factor knockdowns have been 487 generated and analyzed (31, 33, (83) (84) (85) . However, these datasets were obtained in different cell lines, 488 with different amounts of replicates and due to the rapid developments of next-generation 489 sequencing, not using the same technologies. Furthermore, batch effects and divergent approaches of 490 data analyses may contribute to the fact that only a minor overlap of NMD targets could be established 491 so far (31). We compared the results of our CASC3 KO RNA-sequencings to the most recent and 492 comprehensive NMD factor analysis performed by Colombo et al. (31) . The differential expression 493 analysis revealed that many of the top upregulated genes in the CASC3 KO datasets are also 494 significantly affected by UPF1 or SMG6/7 knockdowns (31) and/or encode for small RNA (sRNA) host 495 genes, a previously described class of NMD targets (33). 496
We detected many alternative splicing events in the CASC3 KO data, which was unexpected given 497 that CASC3 was apparently dispensable for the nuclear EJC-related functions. However, we could 498 attribute these splicing patterns to dysfunctional NMD, since isoform-specific algorithms revealed that 499 predominantly PTC-containing transcripts accumulated. A comprehensive bioinformatics analysis 500 workflow and a systematic approach to detect affected transcripts under NMD factor 501 knockdown/knockout conditions could therefore be a crucial step to paint a complete picture of the 502 regulation of transcripts by NMD in the future. Our initial screen of the KO cells showed that compared 503 to the siRNA-mediated CASC3 KD in WT cells, the genomic CASC3 KO cells demonstrated a more 504 pronounced NMD inhibition. It is therefore important to reduce the amount of residual CASC3 protein 505 as much as possible to obtain consistent and robust effects. 506 How exactly CASC3 activates NMD when bound to an EJC, is not yet fully understood. Previously, 507
we reported that the presence of EJCs in the 3′ UTR enhances endonucleolytic cleavage (32). In line 508 with the proposed role as a peripheral NMD-activating EJC component, we observed that CASC3 509 stimulates SMG6-dependent endonucleolytic cleavage, thereby promoting the degradation of NMD-510 targeted transcripts. This effect can be recapitulated by tethering full-length CASC3, its N-terminal two 511 thirds (1-480) or just its N-terminal 137 amino acids to a reporter mRNA. How the small N-terminal 512 region, which cannot assemble into the EJC or contains any known protein domains or sequence motifs 513 can elicit NMD remains to be determined. It is also unclear, if the N-terminus activates translation-514 dependent degradation, as it was previously shown for the full length CASC3 (79). Since the N-terminal 515 segment of CASC3 is a region of low-complexity it could hypothetically undergo liquid-liquid phase 516 separation (LLPS) and be present in condensates with mRNA decay factors, such as processing bodies 517 (P-bodies). In agreement with this idea CASC3 was shown to localize to cytoplasmic granules when 518 overexpressed (86). 519
Our data suggest that CASC3 activates NMD by potentially redundant mechanisms. Binding of 520 CASC3 to the EJC could have an indirect effect on NMD stimulation by increasing the stability of the 521 bound EJC and thus maintaining the possibility of efficient endonucleolytic cleavage of the transcript. 522
An indication for this role comes from the initial in vitro observation that CASC3 stabilizes recombinant 523 EJCs (21). Additionally, the moderately reduced pull-down of UPF3B with EIF4A3 could indicate that 524 cytoplasmic NMD-competent EJCs are less stable in CASC3 KO cells. Alternatively, CASC3 may directly 525 contribute to the recruitment of NMD factors. We therefore propose that CASC3 potentially in 526 conjunction with UPF3B links the EJC with the NMD machinery. In particular, CASC3 influences the 527 contribution of SMG6-mediated endonucleolytic and SMG7-dependent exonucleolytic decay 528 pathways to the overall degradation efficiency of NMD. Accordingly, in wild type cells a knockdown of 529 SMG7 only had a marginal effect on the abundance of the analyzed NMD reporter mRNA, whereas it 530 clearly impaired NMD in CASC3 KO cells. Also, the amount of endonucleolytic cleavage-derived 3′ 531 fragments was reduced when CASC3 is depleted, mirroring the SMG6-knockdown condition. 532
By integrating CASC3 as a specific NMD-activating factor we can now postulate a modified model 533 of EJC-dependent NMD, which is also compatible with several molecular properties of the EJC (Figure  534 7). Since CASC3 is only present in modest amounts in the cytoplasm, it will probably not immediately 535 associate with all EJCs on recently exported mRNPs. This would also not be necessary, since most EJCs 536 are located in the coding sequence and will therefore be removed by the first translating ribosome. 537
However, mRNAs containing PTCs will carry one or more EJCs in their 3′ UTR, which are available for 538 binding of CASC3. The first few translating ribosomes may terminate upstream of CASC3-free EJCs, 539 which could preferentially trigger SMG7-dependent exonucleolytic degradation. Previously, NMD has 540 been proposed to occur primarily in the pioneering round of translation when newly synthesized 541 transcripts are bound to the cap-binding complex (87, 88) . This model has been challenged and there 542 is evidence that NMD can occur on already translating mRNAs and possibly with a constant probability 543 during every round of translation (89-91). Thus, CASC3 could bind to the EJC at a later time point and 544 then increase the probability to activate SMG6-mediated endonucleolytic degradation after each 545 round of termination. Important molecular targets of CASC3 may be mRNAs that escape initial NMD 546 activation, despite containing a PTC (89,92). CASC3 may help to reduce the amount of these mRNAs 547 by maintaining the NMD-activating function of the EJC, either by increasing its stability on the mRNA 548 or via direct interactions with the NMD machinery. This concept would be consistent with the recent 549 observation that NMD targets undergo several rounds of translation before endonucleolytic cleavage 550 occurs (89). 551
In summary, our data paint a picture, in which CASC3 has no essential EJC-related function in the 552 nucleus, but helps to sustain the EJC's ability to induce NMD. We do not exclude the possibility that 553 CASC3 is already associated with the EJC in the nucleus. However, our model of delayed binding of 554 CASC3 to the EJC in the cytoplasm would explain why only a small amount of CASC3 is sufficient to 555 activate EJC-dependent NMD. In this model, CASC3 is an indispensable cytoplasmic component of the 556 EJC that helps to degrade mRNAs that failed to unload all their bound EJCs during the initial rounds of 557 translation. Thus, the binding of CASC3 to the EJC could signal the final round(s) of translation of an 558 mRNA. 559
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Inuganti A: Schematic depiction of the TPI-MS2V5-SMG5 tethering reporter. The reporter consists of the TPI ORF (blue boxes) followed by 4 MS2 stem loops (SL). Downstream the SMG5 3′ untranslated region (UTR) is inserted to increase the size of 3′ fragments that result from cleavage at the termination codon. Reporter and 3′ fragment mRNAs can be detected via the probe binding cassette (gray boxes).
B:
Northern blot of a tethering assay performed in HeLa Tet-Off cells. The cells stably express the tethering reporter shown in Figure 6A together with the indicated MS2V5-tagged proteins. When the cells are additionally treated with XRN1 siRNA, a 3′ degradation fragment can be detected below the full-length reporter. The reporter and 3′ fragment mRNA levels are normalized to the 7SL RNA. For the calculation of the relative mRNA levels in each condition (Luc vs. XRN1) the levels were normalized to the MS2V5-GST control (lanes 1 and 5).
C: Schematic depiction of CASC3 rescue protein constructs. The full-length (FL) protein consists of an N-terminal (blue), C-terminal (orange) and central SELOR domain (purple). The construct 1-480 has a C-terminal deletion, whereas in the construct 110-480 both the N-and C-terminus are truncated. Both deletion constructs were also rendered EJC-binding deficient by mutating the amino acid residues 188 and 218 (F188D, W218D).
D:
Relative quantification of the CLN6 (top) and TOE1 (bottom) transcript isoforms by qPCR in the indicated cell lines. The V5-tagged rescue proteins expressed in the KO condition are shown schematically in Figure 6C . Rescue protein expression is confirmed in Figure 6E and F. Individual data points and means are plotted from n=3 experiments. E and F: Western blot of samples shown in Figure 6D . The expression of rescue proteins was confirmed by an antibody against CASC3 (E) and an antibody recognizing the V5 tag (F). Schematic depiction of the proposed function of CASC3 in the cell. We have found no evidence that CASC3 is necessary for EJC assembly in the nucleus, although CASC3 shuttles between cytoplasm and nucleus. Transcripts that require the deposition of the EJC to be correctly spliced were not affected by a lack of CASC3. In the cytoplasm, premature termination codon (PTC)containing transcripts may still be degraded by NMD during the initial round(s) of translation in a CASC3-independent manner. CASC3 association with the EJC maintains and/or promotes the NMD-stimulating effect of the EJC, resulting in the degradation of transcripts that evaded initial NMD activation.
